Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial
Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page adds new sections and metadata fields, including Last verified, Last known status was:, How to Read a Study Record, Common Questions, How to Join a Study, and a Revision: v3.6.0 tag. It removes older labels such as Verified, Last known status was:, Intervention / Treatment, and Revision: v3.5.5.SummaryDifference2%

- Check19 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a new version of the page content. This change does not alter the substantive study details.SummaryDifference0.1%

- Check41 days agoChange DetectedThe study record's revision history now shows a new revision label v3.5.4, replacing the previous v3.5.3, indicating an updated version of the page.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page footer site revision/version was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check70 days agoChange DetectedThe revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision v3.5.0 was added and v3.4.3 removed, reflecting an update to the study protocol version.SummaryDifference0.1%

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.